REFERENCES

• Clinical Oncology for Medical Students and Physicians, op. cit, pp.32 , 34
• Spontaneous Regression of Cancer: "The Metabolic Triumph of the Host!", op. cit.,pp. 136, 137.
• Manner, HW, Michaelson, TL, and DiSanti, SJ. "Enzymatic Analysis of Normal and Malignant Tissues." Presented at the Illinois State Academy of Science, April 1978. Also, Manner, HW, Michaelson, TL, and DiSanti, SJ, "Amygdalin, Vitamin A and Enzymes Induced Regression of Murine Mammary Adenocarcinomas", Journal of Manipulative and Physiological Therapeutics, Vol 1, No. 4, December 1978. 200 East Roosevelt Road, Lombard, IL 60148 USA
• Vitamin B15 (Pangamic Acid); Properties, Functions, and Use. (Moscow: Science Publishing House, 1965), translated and reprinted by McNaughton Foundation, Sausalito, Calif.
• Catalona, et al. Medical World News, 6/23/72, pg 82M California cancer Advisory council, 1963, pg 10 Weilerstein, R. W., ACS Volunteer, 19, #1, 1973
• Burger, Hospital Practice, July, 1973, 55-62
• Currie & Bagshawe, Lancet, 1, (7492), 708, 1967
• Abercrombie, Ca. Res. 22, 525, 1962
• Cormack, Ca. Res. 30, (5), 1459, 1970
• catalona, et al. Medical World News, 6/23/72, pg 82M
• Jose, Nut. Today, March, 1973, pgs 4-9
• Burk & Winzler, VITAMINS AND HORMONES, vol. II, 1944
• Adcock et al, Science, 181, 8/31/73, 845-47
• Dr. Dean Burk formerly chief of cytochemistry, The National cancer institute, and Dr. John Yiamouyiannis, Science Director of The National Health Federation, Formerly an editor of chemical Abstracts.
• Fairley, Brit. Med. J. 2,1969, 467-473
• Burk, McNaughton, Von Ardenne, PanMinerva Med. 13, #12, Dec. 1971
• Lea, et al, ca. Res. 35, 2321 -2326, Sept. 1975
• The McNaughton Foundation, I.N.D. 6734, April 6, 1970
• Nieper, Krebsgeschehen, 4,1972
• J.A.M.A. 225, 4, July, 1973, pg 424
• Shamberger et al, Proc. Nat, Acad. Sci. May, 1973
• Shute & Shute, ALPHA TOCOPHEROL IN CARDIOVASCULAR DISEASE, Ryerson Press, Toronto, Canada, 1954
• Ransberger, 10th Int. Cancer Congress, 1970
• Wolf & Ransberger, ENZYME THERAPY, Vantage Pr. 1972
• Summa; DipI. Ing. (chem) Landstuhl, 1972
• Reitnauer, Arzneim. Forsch. 22, 1347-61, 1972
• Folkman, Ann. Surg. 175, (3). 409-1 6, 1972
• Penn, 7th Annual Cancer Conf. 1973
• The MEDICAL LETTER, vol. 15, #3 (issue #367) 2/2/73
• Kreuger, ADVANCES IN PHARM. & CHEMOTHERAPY, vol x, 1973
• Prejean & Griswold, NCI Progress Rep. (So. Res. Inst.) 9/72
• Annals New York Academy of Science: 164, 2, 1969
• Sorbo, Acta Chem. Scand. 5, 1951, (724-34); 1953 (1129-1136); 1953 (1137-1145)
• Clemedson et al, Acta Physiol. Scand. 32, 1954, 245
• Engel, Med. Klink. 20, 1790, 1930
• DeFermo, Arch. Ital. de Chir. 33: 801, 1933
• Saphir,~Endocrinol. 18, 191, 1934
• Velasquez & Engel, Endocrinol. 27, 523, 1940
• Li, Med. Clin N. Am. 45, 661 -666, May, 1961
• Roffo, Bol. Inst. de Med. 21, 41 9-586, 1944
• Friedman, Ann. N.Y. Acad. Sci. 80-1 61, 1959 (and refs)
• Krebs & Gurchot, Science, 104, 302, 1946
• Braunstein, et al, Annals Int. Med. 78:39-45, 1973
• Naughton et al, Ca. Res. 35, 1887-1 890, July, 1975
• Wide & Gemzell, Acta Endocrinol. 35-261, 1960
• Navarro, 9th International Cancer Congress, Toyko, Oct. 1966 reported in HEALTH AND LIGHT, by John Ott, D.Sc., Devin Adair, 1973
• Nieper, Agressologie 12, 6,1971, 401-8
• Livingston, CANCER: A NEW BREAKTHROUGH, Nash Publishing, Los Angeles, 1972
• Benno C. Schmidt, chairman of the Memorial Sloan-Kettering Cancer Center, New York City, chairman of The President's Cancer Panel; address to the A.C.S., California Division, Oct. 12, 1973 (Los Angeles Times)
• Yudkin, SWEET AND DANGEROUS, Bantam Books, 1972
• Seminars on Healing, The Academy of Parapsychology and Medicine, June 1973
• Torrance & Schnabel, Ann. Intern. Med. 6, 732, 1932
• Leivy & Schnabel, Am. I. Med. Sd. 183, 381, 1932
• Gillette, et al, I. Clin. Invest. 51, 36a, 1972
• Gillette, et al, New Eng. J. Med. 290, 654, 1974
• Cerami & Manning, Prac. NatI. Acad. Sci. 68, 1180, 1971
• Gillette et al, ibid, 68, 2791, 1971
• Cerami, et al, Fed. Proc. 32, 1668, 1973
• Manning, et al, Adv. Exp. Med. Biol. 28, 253, 1972
• Houston, Am. Laboratory, 7, #10, October, 1975 (and editorial)
• DeLange & Ermans, Am. I. Clin. Nut. 24, 1354, 1971
• Barnes, Broda, M.D., HEART ATTACK RARENESS IN THYROID-TREATED PA TIENTS, C.C. Thomas, 1972
• Barnes and Galton, HYPOTHYROIDISM, THE UNSUSPECTED ILLNESS, Thomas Y. Crowell, N.Y., Feb. 1976
• Smith, J. C. Medical Counterpoint, Nov. 1973
• Oberleas, lntntl. Trace Elements Symp. Modern Med., Sept. 16, 1974
• New Scientist, 5/2/74
• Korant, B.D., Nature, 4/12/74
• Klenner, FR., I. So. Med. & Surg. 111, 209, 1949
• Stacpoole, P.W., Med. Hyp., March-April, 1975

ACKNOWLEDGMENTS

This web-site is the result of a compendium of more than 70 years experience with Vitamin B-17, culled from writings and communications of the following doctors and scientists:

Dr Ernest T. Krebs, jr. Ph.D., D.Sc.
Dr Ernest T. Krebs, Sr. M.D.
Dr N. R. Bouziane, M.D.
Dr Dean Burk, Ph.D.
Dr Ernesto Contreras, M.D.
Dr Francisco Contreras, M.D.
Dr. Harold Manner, M.D.
Dr. Philip Binzel, M.D.
Dr Christian Deckers, M.D.
Dr Ettore Guidetti, M.D.
Dr Charles Gurchot, Ph.D.
Dri. D. Hamilton, M.D.
Dr Maurice Kowan, M.D.
Dr I. Maisin, jr. M.D.
Dr I. Maisin, sr. M.D.
Dr Leon Lewis, M.D.
Dr John A. Morrone, M.D.
Dr Manuel Navarro, M.D.
Dr Hans A. Nieper, M.D.
Edward Spicer, esq.
Dr Emory Thurston, Ph.D., D.Sc.
Dr Prof. Manfred Von Ardenne
Dr. John A. Richardson, M.D.

And many other physicians and scientists whose contributions since the early 1920's laid the groundwork for the present state of the art of physiological management of the metabolic disease of cancer with Vitamin
B-17.

More on B17...